TrialJAMA network open2022

Safety and Short-term Outcomes of High-Dose Erythropoietin in Preterm Infants With Intraventricular Hemorrhage: The EpoRepair Randomized Clinical Trial.

Sven Wellmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.